Biolargo, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 14, 2020 at 04:39 pm EDT
Share
BioLargo, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 418,000 compared to USD 426,000 a year ago. Operating loss was USD 2.005 million compared to USD 1.487 million a year ago. Net loss was USD 2.426 million compared to USD 1.795 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago. For the half year, total revenue was USD 856,000 compared to USD 790,000 a year ago. Operating loss was USD 3.706 million compared to USD 3.149 million a year ago. Net loss was USD 4.699 million compared to USD 4.371 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
BIOLARGO, INC. 
